News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Girindus Not Affected by Solvay's Decision to Sell Pharmaceuticals Sector


9/29/2009 1:34:15 PM

BERGISCH GLADBACH, Germany & CINCINNATI, Ohio--(BUSINESS WIRE)--Girindus, a leading service provider to the pharmaceutical industry and a dedicated manufacturer of therapeutic oligonucleotides, announces that Girindus Group is not affected by Solvay's decision to sell its Pharmaceuticals Sector to Abbott. Girindus is a member of Solvay Organics, which is part of the Chemicals Division of the Solvay Group and is therefore completely separate from the Pharmaceuticals Division.

Read at BioSpace.com

comments powered by Disqus
Girindus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES